Masthead Maestro: Q&A with Manuel Tena-Sempere, MD, PhD, the Next Editor-in-Chief of Endocrinology
High Time: Addressing Research Gaps in Opioid-Associated Endocrine Conditions
Endocrine News speaks with Niki Karavitaki, MSc, PhD, FRCP, of the University of Birmingham, Birmingham Health Partners, and the University Hospitals Birmingham National Health Service Foundation Trust in Birmingham, U.K., chair of the Endocrine Society’s recent Scientific Statement on opioids’ impact on the endocrine system. She discusses gaps in research, as well as why healthcare...
United Kingdom scientists will have access to the world’s largest research collaboration program, Horizon Europe, as the Prime Minister secures a bespoke deal with improved financial terms for the UK’s participation. UK researchers can now apply for grants and bid to take part in projects under the Horizon program, with certainty that the UK will...
Eli Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
[Ed. note: This post has been updated with a comment from Leonard C. Glass, MD, FACE, senior vice president, Lilly Diabetes and Obesity, Global Medical Affairs, Eli Lilly and Company] Eli Lilly and Company today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps...
The Time Is Always Now: The Endocrine Society’s Call to Eliminate Racism in Endocrinology
Never Too Late to Do Good: The Redemption of Stanley Andrisse, PhD, MBA